v3.25.2
Condensed Consolidated Statement of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues        
Interest income $ 18,551,000 $ 8,240,000 $ 34,537,000 $ 12,899,000
Other revenue 1,559,000 2,103,000 2,668,000 3,101,000
Total revenues 20,110,000 10,343,000 37,205,000 16,000,000
Expenses        
Interest expense 12,133,000 4,650,000 22,401,000 7,360,000
General and administrative expenses 1,132,000 865,000 2,081,000 1,695,000
Financing fees 193,000 2,906,000 354,000 3,088,000
Management fees   351,000   412,000
Performance fees 639,000 0 1,199,000 128,000
Total expenses 14,097,000 8,772,000 26,035,000 12,683,000
Gains (losses) from operations and financing        
Unrealized gain (loss) on loans receivable, at fair value 978,000 (1,786,000) 1,924,000 (2,569,000)
Unrealized (loss) gain on secured financings, at fair value (258,000) 1,655,000 (509,000) 1,732,000
Unrealized loss on derivative instruments, net (2,532,000) (474,000) (3,515,000) (474,000)
Gain on foreign currency translation 2,390,000 564,000 3,585,000 564,000
Total gain (loss) from operations and financing, net 578,000 (41,000) 1,485,000 (747,000)
Net income $ 6,591,000 $ 1,530,000 $ 12,655,000 $ 2,570,000
Net income per common share, basic $ 0.54 $ 0.21 $ 1.07 $ 0.47
Net income per common share, diluted $ 0.54 $ 0.21 $ 1.07 $ 0.47
Weighted-average common shares outstanding, basic 12,301,032 7,230,612 11,805,619 5,420,360
Weighted-average common shares outstanding, diluted [1] 12,302,358 7,232,007 11,806,572 5,421,381
[1] Diluted earnings per share takes into account the effect of dilutive instruments, such as unvested common share awards. As of June 30, 2025, 2,932 unvested common shares were outstanding.